The specific impact of DTG, BIC and TAF on weight gain/obesity in PWH is confirmed in
different populations independently of the weight limiting effect of EFV and TDF. ART-linked …

Introduction Globally about 1.7 million children were living with HIV in 2020. Two integrase
strand transfer inhibitors, dolutegravir and raltegravir, are increasingly used in children. We …

Background: With the growing population of HIV-exposed uninfected (HEU) children
globally, it is important to determine population-level growth differences between HEU and …

Background Pediatric HIV infection cause retardation in height and weight. However,
effective antiretroviral therapy (ART) result in desirable weight gain. Concerns have …

Background Integrase inhibitor (INSTI) with boosted darunavir (DRV/r), a regimen with a
high-resistance barrier, avoiding NRTI toxicities, might be a switching option in children …

Background: Despite encouraging results from clinical trials and in high-income countries,
large-scale data on the effectiveness and safety of dolutegravir (DTG) in children and …

Introduction Body mass index (BMI) is a simple and cost-effective tool for monitoring the
clinical responses of patients living with human immunodeficiency virus (HIV) after …

Nutritional status is considered a major diagnostic and prognostic indicator of HIV/AIDS in
adults. In this aspect, current HIV-treatment guidelines, particularly in low-income countries …

Dolutegravir (DTG) is a pivotal antiretroviral medicine that has become the backbone of
several HIV programmes, especially in sub-Saharan African countries. It has recently …

Introduction The course of HIV infection has changed radically with the introduction of
antiretroviral therapy (ART), which has significantly reduced mortality and improved quality …